112 related articles for article (PubMed ID: 504837)
1. [Chronic pulmonary reaction after nitrofurantoin (author's transl)].
Ancic P; Ferretti R
Rev Med Chil; 1979 Apr; 107(4):319-23. PubMed ID: 504837
[No Abstract] [Full Text] [Related]
2. [Nitrofurantoin-induced chronic pulmonary fibrosis (author's transl)].
Haas W; Münzenmaier R; Loewe KR
Dtsch Med Wochenschr; 1973 Oct; 98(40):1867-71. PubMed ID: 4762042
[No Abstract] [Full Text] [Related]
3. The effect of tiotropium on the pulmonary diffusing capacity.
Gonlugur U
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
[TBL] [Abstract][Full Text] [Related]
4. [Effect of two cardioselective beta adrenergic blocking agents on patients with chronic obstructive lung disease(author's transl)].
Pantzer M
Schweiz Rundsch Med Prax; 1975 Jun; 64(23):721-6. PubMed ID: 1161744
[No Abstract] [Full Text] [Related]
5. Nitrofurantoin-induced alterations in pulmonary tissue. A report on five patients with acute or subacute reactions.
Taskinen E; Tukiainen P; Sovijarvi AR
Acta Pathol Microbiol Scand A; 1977 Sep; 85(5):713-20. PubMed ID: 920185
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced lung disease.
Whitcomb ME; Domby WR
Prim Care; 1978 Sep; 5(3):411-23. PubMed ID: 102005
[TBL] [Abstract][Full Text] [Related]
7. [Nitrofurantoin induced hypersensitivity reactions in the lungs].
Sovijärvi AR; Lemola M; Stenius B; Taskinen E; Tukiainen P; Idänpään-Heikkilä J
Duodecim; 1976; 92(5):227-41. PubMed ID: 1261438
[No Abstract] [Full Text] [Related]
8. Nitrofurantoin-induced acute, subacute and chronic pulmonary reactions.
Sovijärvi AR; Lemola M; Stenius B; Idänpään-Heikkilä J
Scand J Respir Dis; 1977; 58(1):41-50. PubMed ID: 841294
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary fibrosis secondary to nitrofurantoin].
Pérez Herms S; Castellanos Acosta R; Guzmán Fernández A; Cortadellas Angel R; Ballesteros Sampol JJ
Arch Esp Urol; 1992; 45(6):577-8. PubMed ID: 1510501
[TBL] [Abstract][Full Text] [Related]
10. The effect of diffuse pulmonary fibrosis on lung mechanics.
Murphy DM; Hall DR; Petersen MR; Lapp NL
Bull Eur Physiopathol Respir; 1981; 17(1):27-41. PubMed ID: 7470684
[TBL] [Abstract][Full Text] [Related]
11. Nitrofurantoin induced chronic pulmonary reaction: case report.
Robinson GM; Bai TR; Steele RH
N Z Med J; 1980 Jan; 91(652):50-2. PubMed ID: 6929438
[No Abstract] [Full Text] [Related]
12. Interstitial lung disease caused by chronic nitrofurantoin reaction; case report.
Qureshi MM
Wis Med J; 1984 Sep; 83(9):20-2. PubMed ID: 6485363
[No Abstract] [Full Text] [Related]
13. [Obstructive pulmonary emphysema. Evolution of various parameters of pulmonary function and its correlation].
Alatriste VM; León E; Galland F
Arch Inst Cardiol Mex; 1975; 45(4):453-9. PubMed ID: 1180609
[TBL] [Abstract][Full Text] [Related]
14. Diurnal variation in pulmonary diffusing capacity and expiratory volumes.
Panda A; McHardy G
Indian J Physiol Pharmacol; 1980; 24(2):112-8. PubMed ID: 7189745
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary fibrosis and nitrofurantoin.
Israel KS; Brashear RE; Sharma HM; Yum MN; Glover JL
Am Rev Respir Dis; 1973 Aug; 108(2):353-6. PubMed ID: 4720696
[No Abstract] [Full Text] [Related]
16. [Evaluation of remaining performance capacity in patients with alveolitis and pulmonary fibrosis].
Pielesch W; Liebetrau G
Z Erkr Atmungsorgane; 1987; 168(1):89-94. PubMed ID: 3577250
[TBL] [Abstract][Full Text] [Related]
17. Effects on diffusing capacity and ventilation--perfusion relationships of budesonide inhalations for 2 months in chronic obstructive pulmonary disease (COPD).
Sandek K; Bratel T; Lagerstrand L
Respir Med; 2001 Aug; 95(8):676-84. PubMed ID: 11530957
[TBL] [Abstract][Full Text] [Related]
18. Progressive pulmonary fibrosis during nitrofurantoin therapy. A case history with autopsy report.
Ruikka I; Vaissalo T; Saarimaa H
Scand J Respir Dis; 1971; 52(3):162-6. PubMed ID: 5161828
[No Abstract] [Full Text] [Related]
19. [A 45-year-old patient with a progressive, currently therapy-resistant disease of the lung].
König G; Remberger K; Höfling B; Erdmann E; Fruhmann G
Internist (Berl); 1986 Jan; 27(1):65-9. PubMed ID: 3082788
[No Abstract] [Full Text] [Related]
20. Action of isoprenaline on the mechanical properties of lungs and airways in healthy people and patients with obstructive lung diseases.
Bobbaers H; Stanescu DC; Demedts SM; Clément J; Pardaens J; van de Woestijne KP
Bull Eur Physiopathol Respir; 1976; 12(4):515-31. PubMed ID: 1087891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
